Mr. Vincent Lum reports

PANGENOMIC HEALTH SUBSIDIARY INTRODUCES POINT-OF-CARE VITAMIN D TEST FOR THE DENTAL IMPLANT INDUSTRY

Pangenomic Health Inc.'s subsidiary, MUJN Diagnostics Inc., has introduced its point-of-care vitamin D test for the dental implant industry.

"Vitamin D can play a significant role in the success of a dental implant procedure," said Dr. William Liang, diplomat of the American Board of Oral Implantology, and owner of the Smile Dental Implant Centre in Surrey, B.C. "The MUJN biomarker platform can help our patients avoid potential dental implant failures that may be caused by the negative effect of vitamin D deficiencies on osseointegration." The Smile Dental Implant Centre is the first dental clinic customer of MUJN Diagnostics.

"We are very excited to expand our MUJN biomarker assessment platform beyond our initial focus of tracking precision medicine treatments for mental health conditions," said Vincent Lum, chief executive officer of MUJN Diagnostics and co-founder of Pangenomic Health. "We believe there will be increasing demand from health practitioners in many fields for rapid point-of-care diagnostic tests of biomarkers to facilitate precision health. We believe the dental implant industry is a particularly promising market for our diagnostics platform, as there are over 500,000 dental implants placed annually in the U.S."

Current clinical research on vitamin D has found that:

• Vitamin D deficiency has been linked with an increase of up to 300 per cent in the failure rate for dental implants.
• Insufficient intake of vitamin D occurs in more than 25 per cent of the United States population, and in over one billion people globally.

About MUJN Diagnostics Inc.

MUJN Diagnostics is a wholly owned subsidiary of Pangenomic Health and is focused on developing a decision support system for alternative health care providers. MUJN's decision support system will include biomarker diagnostics, symptom and treatment tracking, and personalized health analytics, with the goal of empowering health care providers and their patients toward better outcomes.

About Pangenomic Health Inc.

Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company's initial focus is to support mental health. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

We seek Safe Harbor.